+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Flow Cytometry in Oncology & Immunology Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 195 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5924942
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The flow cytometry market within oncology and immunology is undergoing significant advancement, marked by developments in instrumentation, reagents, and analytics that collectively redefine cell analysis and therapeutic pathways in both research and clinical environments. Senior executives monitoring market trends must anticipate evolving procurement drivers, workflow demands, and regulatory pressure shaping this integrated sector.

Market Snapshot: Flow Cytometry in Oncology & Immunology

The Flow Cytometry in Oncology & Immunology Market is positioned for robust growth, expanding from USD 405.04 million in 2025 to USD 430.20 million in 2026. A projected compound annual growth rate (CAGR) of 5.56% will drive market value to USD 591.58 million by 2032. This upward trajectory stems from heightened adoption in both research and clinical diagnostics, influenced by a shift toward high-throughput platforms, validated reagents, and automation. Senior procurement and strategy teams must recognize how innovation is widening the adoption curve, while varied regional and regulatory environments create nuanced opportunities. A clear understanding of demand patterns and supply chain dynamics underpins decisions in this competitive landscape.

Scope & Segmentation

  • Product Types: The market covers bench top analyzers, high-throughput analyzers, and specialized cell sorters, alongside key consumables such as calibration beads, fluorochrome-conjugated antibodies, and ready-to-use kits. This breadth allows alignment with both routine and advanced laboratory needs, supporting flexibility in procurement and implementation strategies.
  • Technology Segments: The landscape features conventional multicolor flow cytometry, advanced imaging flow cytometry, and mass cytometry. Each technology supports applications ranging from deep cellular phenotyping to spatial biology and broad proteomic profiling, enabling more nuanced and comprehensive workflow customization for varied research and diagnostic goals.
  • Applications: Major use cases include cell therapy development (notably CAR T and dendritic cell workflows), clinical diagnostics in oncology and immunology, and core research functions. Adoption is often driven by the need to optimize sensitivity, support emerging therapies, and maintain regulatory standards in high-impact settings.
  • End Users: Solutions address the specific requirements of academic institutions, contract research organizations, hospitals and clinics, and pharmaceutical and biotechnology companies. This focus highlights different procurement cycles, compliance levels, and needs for modular or integrated solutions across the user base.
  • Geographies: Americas, EMEA, and the Asia-Pacific regions all play pivotal roles in shaping flow cytometry adoption. Diversified regulatory frameworks and disparate supply chain strategies necessitate local adaptation and present differentiated growth opportunities, particularly as regional manufacturing and distribution models mature.

Key Takeaways

  • Integration of instrument hardware with validated reagent kits increasingly shapes procurement, ensuring compatibility and reducing onboarding time for laboratories and clinical sites.
  • Automation, modularity, and seamless connectivity with laboratory information management systems are top priorities, driving investment in scalable platforms that support digital transformation in diagnostics and research operations.
  • Emerging technology solutions are broadening the reach of high-parameter cell analysis, enhancing data granularity and minimizing the manual intervention required for sophisticated protocols across the market.
  • Workflow diversity is apparent across customer segments, from the flexibility needed in academic and research settings to the rigorous compliance and documentation requirements in regulated clinical laboratories and biopharma entities.
  • Strategic partnerships—including service contracts and co-development with contract research organizations and pharmaceutical firms—are central to maximizing value, fostering innovation, and supporting responsive customer service in a changing regulatory landscape.
  • Robust supply chain management that emphasizes local inventory and regional manufacturing is now crucial, with stakeholders seeking to mitigate operational risks and minimize lead times amid global uncertainty and fluctuating demand.

Tariff Impact on Flow Cytometry Procurement and Supply Chains

Tariffs, including recent US policy measures, are significantly affecting cost structures for instruments and reagents, prompting buyers to adapt sourcing strategies. Many procurement leaders are shifting toward regional suppliers and building flexibility into agreements to counteract price fluctuations. Vendors now prioritize transparency in pricing, increase localized production, and upgrade logistics systems to ensure reliable supply and operational stability for customers navigating uncertain market conditions.

Methodology & Data Sources

This market assessment draws on expert interviews, insights from clinical laboratory leaders and instrument specialists, and feedback from frontline end users. Analysis is supported by technical literature, current regulatory guidance, and verified supply chain data, while peer-reviewed research and vendor specifications refine segmentation and trend analysis. All findings undergo expert review to ensure alignment with evolving sector standards.

Why This Report Matters

  • Supports senior decision-makers and procurement leaders in proactively aligning purchasing strategies with emerging trends in the oncology and immunology flow cytometry market.
  • Provides clarity on regulatory developments, technology integration, and regional supply chain concerns to ensure robust, informed investment decisions.
  • Delivers actionable guidance for evaluating partnerships, system upgrades, and reagent qualification, ultimately driving efficiency and accelerating pathways from research to clinical application.

Conclusion

Meeting evolving market standards in oncology and immunology flow cytometry relies on integrated product solutions, proactive compliance preparation, and adaptive supply strategies. This analysis enables stakeholders to anticipate challenges and capitalize on opportunities for sustainable impact and growth.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Flow Cytometry in Oncology & Immunology Market, by Product Type
8.1. Instruments
8.1.1. Cell Analyzers
8.1.1.1. Bench Top Analyzers
8.1.1.2. High Throughput Analyzers
8.1.2. Cell Sorters
8.1.2.1. Microfluidic Sorters
8.1.2.2. Nozzle Based Sorters
8.2. Reagents & Consumables
8.2.1. Consumables
8.2.1.1. Calibration Beads
8.2.1.2. Tubes & Plates
8.2.2. Reagents
8.2.2.1. Fluorochrome Antibodies
8.2.2.2. Kits
9. Flow Cytometry in Oncology & Immunology Market, by Technology
9.1. Conventional Flow Cytometry
9.1.1. Multicolor Cytometry
9.1.1.1. Eight Or More Color Cytometry
9.1.1.2. Four Color Cytometry
9.1.2. Two Color Cytometry
9.2. Imaging Flow Cytometry
9.3. Mass Cytometry
10. Flow Cytometry in Oncology & Immunology Market, by Application
10.1. Cell Therapy
10.1.1. CAR T Cell Therapy
10.1.2. Dendritic Cell Therapy
10.2. Clinical Diagnostics
10.2.1. Immunology Diagnostics
10.2.2. Oncology Diagnostics
10.3. Research
10.3.1. Immunology Research
10.3.2. Oncology Research
11. Flow Cytometry in Oncology & Immunology Market, by End User
11.1. Academic Institutions
11.2. Contract Research Organizations
11.3. Hospitals & Clinics
11.4. Pharmaceutical Biotechnology Companies
11.5. Research Laboratories
12. Flow Cytometry in Oncology & Immunology Market, by Region
12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific
13. Flow Cytometry in Oncology & Immunology Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Flow Cytometry in Oncology & Immunology Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. United States Flow Cytometry in Oncology & Immunology Market
16. China Flow Cytometry in Oncology & Immunology Market
17. Competitive Landscape
17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. Agilent Technologies, Inc.
17.6. Apogee Flow Systems Ltd.
17.7. Becton, Dickinson and Company
17.8. Bio-Rad Laboratories, Inc.
17.9. bioMérieux SA
17.10. Cytek Biosciences, Inc.
17.11. Enzo Life Sciences, Inc.
17.12. General Electric Company
17.13. GenScript Biotech Corporation
17.14. Merck KGaA
17.15. Miltenyi Biotec B.V. & CO. KG
17.16. Nanocellect Biomedical, Inc.
17.17. Novozymes A/S
17.18. On-Chip Biotechnologies Co., Ltd.
17.19. RareCyte, Inc.
17.20. Sartorius AG
17.21. Sony Biotechnology Inc.
17.22. Stratedigm, Inc.
17.23. Sysmex Corporation
17.24. Thermo Fisher Scientific, Inc.
17.25. Union Biometrica, Inc.
List of Figures
FIGURE 1. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. UNITED STATES FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 12. CHINA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CELL ANALYZERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CELL ANALYZERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CELL ANALYZERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CELL ANALYZERS, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY BENCH TOP ANALYZERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY BENCH TOP ANALYZERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY BENCH TOP ANALYZERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY HIGH THROUGHPUT ANALYZERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY HIGH THROUGHPUT ANALYZERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY HIGH THROUGHPUT ANALYZERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CELL SORTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CELL SORTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CELL SORTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CELL SORTERS, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY MICROFLUIDIC SORTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY MICROFLUIDIC SORTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY MICROFLUIDIC SORTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY NOZZLE BASED SORTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY NOZZLE BASED SORTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY NOZZLE BASED SORTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY REAGENTS & CONSUMABLES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY REAGENTS & CONSUMABLES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CONSUMABLES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CALIBRATION BEADS, BY REGION, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CALIBRATION BEADS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CALIBRATION BEADS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TUBES & PLATES, BY REGION, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TUBES & PLATES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TUBES & PLATES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY REAGENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY REAGENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY REAGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLUOROCHROME ANTIBODIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLUOROCHROME ANTIBODIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLUOROCHROME ANTIBODIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY KITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY KITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY KITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CONVENTIONAL FLOW CYTOMETRY, BY REGION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CONVENTIONAL FLOW CYTOMETRY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CONVENTIONAL FLOW CYTOMETRY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CONVENTIONAL FLOW CYTOMETRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY MULTICOLOR CYTOMETRY, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY MULTICOLOR CYTOMETRY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY MULTICOLOR CYTOMETRY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY MULTICOLOR CYTOMETRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY EIGHT OR MORE COLOR CYTOMETRY, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY EIGHT OR MORE COLOR CYTOMETRY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY EIGHT OR MORE COLOR CYTOMETRY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FOUR COLOR CYTOMETRY, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FOUR COLOR CYTOMETRY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FOUR COLOR CYTOMETRY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TWO COLOR CYTOMETRY, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TWO COLOR CYTOMETRY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TWO COLOR CYTOMETRY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY IMAGING FLOW CYTOMETRY, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY IMAGING FLOW CYTOMETRY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY IMAGING FLOW CYTOMETRY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY MASS CYTOMETRY, BY REGION, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY MASS CYTOMETRY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY MASS CYTOMETRY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CELL THERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CELL THERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CELL THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CELL THERAPY, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CAR T CELL THERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CAR T CELL THERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CAR T CELL THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY DENDRITIC CELL THERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY DENDRITIC CELL THERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY DENDRITIC CELL THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY IMMUNOLOGY DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY IMMUNOLOGY DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY IMMUNOLOGY DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY ONCOLOGY DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY ONCOLOGY DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY ONCOLOGY DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY RESEARCH, BY REGION, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY IMMUNOLOGY RESEARCH, BY REGION, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY IMMUNOLOGY RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY IMMUNOLOGY RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY ONCOLOGY RESEARCH, BY REGION, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY ONCOLOGY RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY ONCOLOGY RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PHARMACEUTICAL BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PHARMACEUTICAL BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PHARMACEUTICAL BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY RESEARCH LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY RESEARCH LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 123. AMERICAS FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 124. AMERICAS FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 125. AMERICAS FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 126. AMERICAS FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CELL ANALYZERS, 2018-2032 (USD MILLION)
TABLE 127. AMERICAS FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CELL SORTERS, 2018-2032 (USD MILLION)
TABLE 128. AMERICAS FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 129. AMERICAS FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 130. AMERICAS FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 131. AMERICAS FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 132. AMERICAS FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CONVENTIONAL FLOW CYTOMETRY, 2018-2032 (USD MILLION)
TABLE 133. AMERICAS FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY MULTICOLOR CYTOMETRY, 2018-2032 (USD MILLION)
TABLE 134. AMERICAS FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 135. AMERICAS FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CELL THERAPY, 2018-2032 (USD MILLION)
TABLE 136. AMERICAS FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 137. AMERICAS FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
TABLE 138. AMERICAS FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 139. NORTH AMERICA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 140. NORTH AMERICA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 141. NORTH AMERICA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 142. NORTH AMERICA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CELL ANALYZERS, 2018-2032 (USD MILLION)
TABLE 143. NORTH AMERICA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CELL SORTERS, 2018-2032 (USD MILLION)
TABLE 144. NORTH AMERICA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 145. NORTH AMERICA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 146. NORTH AMERICA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 147. NORTH AMERICA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 148. NORTH AMERICA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CONVENTIONAL FLOW CYTOMETRY, 2018-2032 (USD MILLION)
TABLE 149. NORTH AMERICA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY MULTICOLOR CYTOMETRY, 2018-2032 (USD MILLION)
TABLE 150. NORTH AMERICA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 151. NORTH AMERICA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CELL THERAPY, 2018-2032 (USD MILLION)
TABLE 152. NORTH AMERICA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 153. NORTH AMERICA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
TABLE 154. NORTH AMERICA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 155. LATIN AMERICA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 156. LATIN AMERICA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 157. LATIN AMERICA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 158. LATIN AMERICA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CELL ANALYZERS, 2018-2032 (USD MILLION)
TABLE 159. LATIN AMERICA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CELL SORTERS, 2018-2032 (USD MILLION)
TABLE 160. LATIN AMERICA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 161. LATIN AMERICA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 162. LATIN AMERICA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 163. LATIN AMERICA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 164. LATIN AMERICA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CONVENTIONAL FLOW CYTOMETRY, 2018-2032 (USD MILLION)
TABLE 165. LATIN AMERICA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY MULTICOLOR CYTOMETRY, 2018-2032 (USD MILLION)
TABLE 166. LATIN AMERICA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 167. LATIN AMERICA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CELL THERAPY, 2018-2032 (USD MILLION)
TABLE 168. LATIN AMERICA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 169. LATIN AMERICA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
TABLE 170. LATIN AMERICA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CELL ANALYZERS, 2018-2032 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CELL SORTERS, 2018-2032 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CONVENTIONAL FLOW CYTOMETRY, 2018-2032 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY MULTICOLOR CYTOMETRY, 2018-2032 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CELL THERAPY, 2018-2032 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 187. EUROPE FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 188. EUROPE FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 189. EUROPE FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 190. EUROPE FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CELL ANALYZERS, 2018-2032 (USD MILLION)
TABLE 191. EUROPE FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CELL SORTERS, 2018-2032 (USD MILLION)
TABLE 192. EUROPE FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 193. EUROPE FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 194. EUROPE FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 195. EUROPE FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 196. EUROPE FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CONVENTIONAL FLOW CYTOMETRY, 2018-2032 (USD MILLION)
TABLE 197. EUROPE FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY MULTICOLOR CYTOMETRY, 2018-2032 (USD MILLION)
TABLE 198. EUROPE FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 199. EUROPE FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CELL THERAPY, 2018-2032 (USD MILLION)
TABLE 200. EUROPE FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 201. EUROPE FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
TABLE 202. EUROPE FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 203. MIDDLE EAST FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 204. MIDDLE EAST FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 205. MIDDLE EAST FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 206. MIDDLE EAST FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CELL ANALYZERS, 2018-2032 (USD MILLION)
TABLE 207. MIDDLE EAST FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CELL SORTERS, 2018-2032 (USD MILLION)
TABLE 208. MIDDLE EAST FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 209. MIDDLE EAST FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 210. MIDDLE EAST FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 211. MIDDLE EAST FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 212. MIDDLE EAST FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CONVENTIONAL FLOW CYTOMETRY, 2018-2032 (USD MILLION)
TABLE 213. MIDDLE EAST FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY MULTICOLOR CYTOMETRY, 2018-2032 (USD MILLION)
TABLE 214. MIDDLE EAST FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 215. MIDDLE EAST FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CELL THERAPY, 2018-2032 (USD MILLION)
TABLE 216. MIDDLE EAST FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 217. MIDDLE EAST FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
TABLE 218. MIDDLE EAST FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 219. AFRICA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 220. AFRICA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 221. AFRICA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 222. AFRICA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CELL ANALYZERS, 2018-2032 (USD MILLION)
TABLE 223. AFRICA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CELL SORTERS, 2018-2032 (USD MILLION)
TABLE 224. AFRICA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 225. AFRICA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 226. AFRICA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 227. AFRICA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 228. AFRICA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CONVENTIONAL FLOW CYTOMETRY, 2018-2032 (USD MILLION)
TABLE 229. AFRICA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY MULTICOLOR CYTOMETRY, 2018-2032 (USD MILLION)
TABLE 230. AFRICA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 231. AFRICA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CELL THERAPY, 2018-2032 (USD MILLION)
TABLE 232. AFRICA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 233. AFRICA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
TABLE 234. AFRICA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 235. ASIA-PACIFIC FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 236. ASIA-PACIFIC FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 237. ASIA-PACIFIC FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 238. ASIA-PACIFIC FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CELL ANALYZERS, 2018-2032 (USD MILLION)
TABLE 239. ASIA-PACIFIC FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CELL SORTERS, 2018-2032 (USD MILLION)
TABLE 240. ASIA-PACIFIC FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 241. ASIA-PACIFIC FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 242. ASIA-PACIFIC FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 243. ASIA-PACIFIC FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 244. ASIA-PACIFIC FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CONVENTIONAL FLOW CYTOMETRY, 2018-2032 (USD MILLION)
TABLE 245. ASIA-PACIFIC FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY MULTICOLOR CYTOMETRY, 2018-2032 (USD MILLION)
TABLE 246. ASIA-PACIFIC FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 247. ASIA-PACIFIC FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CELL THERAPY, 2018-2032 (USD MILLION)
TABLE 248. ASIA-PACIFIC FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 249. ASIA-PACIFIC FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
TABLE 250. ASIA-PACIFIC FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 251. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 252. ASEAN FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 253. ASEAN FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 254. ASEAN FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 255. ASEAN FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CELL ANALYZERS, 2018-2032 (USD MILLION)
TABLE 256. ASEAN FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CELL SORTERS, 2018-2032 (USD MILLION)
TABLE 257. ASEAN FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 258. ASEAN FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 259. ASEAN FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 260. ASEAN FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 261. ASEAN FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CONVENTIONAL FLOW CYTOMETRY, 2018-2032 (USD MILLION)
TABLE 262. ASEAN FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY MULTICOLOR CYTOMETRY, 2018-2032 (USD MILLION)
TABLE 263. ASEAN FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 264. ASEAN FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CELL THERAPY, 2018-2032 (USD MILLION)
TABLE 265. ASEAN FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 266. ASEAN FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
TABLE 267. ASEAN FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 268. GCC FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 269. GCC FLOW CYTOMETRY IN ONC

Companies Mentioned

The key companies profiled in this Flow Cytometry in Oncology & Immunology market report include:
  • Agilent Technologies, Inc.
  • Apogee Flow Systems Ltd.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • bioMérieux SA
  • Cytek Biosciences, Inc.
  • Enzo Life Sciences, Inc.
  • General Electric Company
  • GenScript Biotech Corporation
  • Merck KGaA
  • Miltenyi Biotec B.V. & CO. KG
  • Nanocellect Biomedical, Inc.
  • Novozymes A/S
  • On-Chip Biotechnologies Co., Ltd.
  • RareCyte, Inc.
  • Sartorius AG
  • Sony Biotechnology Inc.
  • Stratedigm, Inc.
  • Sysmex Corporation
  • Thermo Fisher Scientific, Inc.
  • Union Biometrica, Inc.

Table Information